Save on this medicine
Other brands with the same active ingredient
These brands contain the same active ingredient (Ranolazine). Strength and form may differ — confirm substitution with your doctor or pharmacist before switching.
ইঙ্গিত ও ব্যবহার
Ralozine এর জন্য নির্দেশিত:
ডোজ নির্দেশিকা
শুধুমাত্র নির্দেশিকা তথ্য
প্রদর্শিত ডোজগুলি সরকারি উৎসের সাধারণ নির্দেশিকা। ব্যক্তিগতকৃত ডোজের জন্য সর্বদা আপনার ডাক্তার বা ফার্মাসিস্টের পরামর্শ নিন।
Adults:
Ranolazine is usually started at 500 mg twice daily. Depending on how well symptoms are controlled, the dose may be increased to 1000 mg twice daily, which is also the maximum recommended daily dose. Ranolazine can be taken with or without meals. The tablets should be swallowed whole and should not be crushed, broken or chewed. If a dose is missed, the next dose should be taken at its regular scheduled time; the dose should not be doubled to make up for the one missed. Pediatric use: the safety and effectiveness of Ranolazine in pediatric patients have not been established.
পার্শ্বপ্রতিক্রিয়া
Bradycardia and palpitations (Cardiac Disorders); tinnitus and vertigo (Ear and Labyrinth Disorders); abdominal pain, dry mouth, and vomiting (Gastrointestinal Disorders); peripheral edema (General Disorders and Administrative Site Adverse Events); dyspnea (Respiratory, Thoracic, and Mediastinal Disorders); and hypotension and orthostatic hypotension (Vascular Disorders).
সতর্কতা ও নিষেধাজ্ঞা
Warnings & Precautions
Antogin ER blocks QTc and prolongs the QTc interval in a dose-related manner. Clinical experience in an acute coronary syndrome population did not show an increased risk of proarrhythmia or sudden death.Co-administration of Antogin ER with digoxin increases the plasma concentrations of digoxin by approximately 1.5-fold and the dose of digoxin may have to be reduced accordingly. The dose of other P-gp substrates may have to be reduced as well when Antogin ER Is co-admlnistered. Caution should be exercised when co-adminlstering Antogin ER with P-gp inhibitors such as ritonavir or cydosporine.
নিষেধাজ্ঞা
Ranolazine is contraindicated in patients: With pre-existing QT prolongation With hepatic impairment Taking QT prolonging drugs Taking potent and moderately potent CYP3A inhibitors such as ketoconazole, itraconazole, clarithromycin, nefazodone, nelfinavir, ritonavir, indinavir, and saquinavir, including diltiazem.